DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Sharma P, Callahan MK, Bono P. et al.
Nivolumab monotherapy in recurrent metastatic urothelial carcinoma (CheckMate 032): a multicentre, open-label, two-stage, multi-arm, phase 1/2 trial.
The Lancet Oncology 2016;
17: 1590-1598
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.